125 related articles for article (PubMed ID: 24462709)
21. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.
Evanko SP; Johnson PY; Braun KR; Underhill CB; Dudhia J; Wight TN
Arch Biochem Biophys; 2001 Oct; 394(1):29-38. PubMed ID: 11566024
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.
Lemire JM; Chan CK; Bressler S; Miller J; LeBaron RG; Wight TN
J Cell Biochem; 2007 Jun; 101(3):753-66. PubMed ID: 17226775
[TBL] [Abstract][Full Text] [Related]
23. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).
Chen Z; Lee FY; Bhalla KN; Wu J
Mol Pharmacol; 2006 May; 69(5):1527-33. PubMed ID: 16436588
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
25. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
26. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.
Ballinger ML; Ivey ME; Osman N; Thomas WG; Little PJ
Atherosclerosis; 2009 Aug; 205(2):451-7. PubMed ID: 19217622
[TBL] [Abstract][Full Text] [Related]
27. Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway.
Han HJ; Kim TJ; Jin YR; Hong SS; Hwang JH; Hwang BY; Lee KH; Park TK; Yun YP
Planta Med; 2007 Sep; 73(11):1163-8. PubMed ID: 17713875
[TBL] [Abstract][Full Text] [Related]
28. The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle.
Rostam MA; Kamato D; Piva TJ; Zheng W; Little PJ; Osman N
Cell Signal; 2016 Aug; 28(8):956-66. PubMed ID: 27153775
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
Humar R; Kiefer FN; Berns H; Resink TJ; Battegay EJ
FASEB J; 2002 Jun; 16(8):771-80. PubMed ID: 12039858
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor-BB-mediated glycosaminoglycan synthesis is transduced through Akt.
Cartel NJ; Wang J; Post M
Biochem J; 2002 Apr; 363(Pt 1):19-28. PubMed ID: 11903042
[TBL] [Abstract][Full Text] [Related]
32. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
Spacey GD; Uings IJ; Slater M; Hirst S; Bonser RW
Biochem Pharmacol; 1998 Feb; 55(3):261-71. PubMed ID: 9484791
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis.
Lozano E; Segarra M; García-Martínez A; Hernández-Rodríguez J; Cid MC
Ann Rheum Dis; 2008 Nov; 67(11):1581-8. PubMed ID: 17584806
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor.
Keyes LE; Moore LG; Walchak SJ; Dempsey EC
J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771
[TBL] [Abstract][Full Text] [Related]
35. Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genes.
Kamato D; Burch M; Zhou Y; Mohamed R; Stow JL; Osman N; Zheng W; Little PJ
Cell Signal; 2019 Jan; 53():365-373. PubMed ID: 30423352
[TBL] [Abstract][Full Text] [Related]
36. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
37. PDGF-stimulated cell proliferation and migration of human arterial smooth muscle cells. Colocalization of PDGF isoforms with glycosaminoglycans.
García-Olivas R; Vilaró S; Reina M; Castel S
Int J Biochem Cell Biol; 2007; 39(10):1915-29. PubMed ID: 17616478
[TBL] [Abstract][Full Text] [Related]
38. PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts.
Rauch BH; Weber A; Braun M; Zimmermann N; Schrör K
FEBS Lett; 2000 Sep; 481(1):3-7. PubMed ID: 10984605
[TBL] [Abstract][Full Text] [Related]
39. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.
Burch ML; Ballinger ML; Yang SNY; Getachew R; Itman C; Loveland K; Osman N; Little PJ
J Biol Chem; 2010 Aug; 285(35):26798-26805. PubMed ID: 20571025
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells.
Schönherr E; Järveläinen HT; Kinsella MG; Sandell LJ; Wight TN
Arterioscler Thromb; 1993 Jul; 13(7):1026-36. PubMed ID: 8318504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
